
Dr. Soonmo Peter Kang MD
Hematologist-Oncologist | Hematology & Oncology
5841 S Maryland Ave # Mc2115 Room Ab 107 Chicago IL, 60637About
Dr. Soonmo Kang is a hematologist oncologist practicing in Chicago, IL. Dr. Kang specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Presentation of extramedullary acute myelogenous leukemia as bilateral testicular masses: response to non-myeloablative allogeneic transplantation.
- Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies.
- Long-term survival on capecitabine in two gemcitabine refractory pancreatic cancer patients. Is there a pharmacogenetic explanation?
- Infusion-related and hypersensitivity reactions of monoclonal antibodies used to treat colorectal cancer--identification, prevention, and management.
- Optimal second line treatment options for gemcitabine refractory advanced pancreatic cancer patients. Can we establish standard of care with available data?
- Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management.
- Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapy.
- Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
- Three-drug combination regimen in pancreatic cancer treatment: are we there yet?
- Ampullary and periampullary tumors: translational efforts to meet a challenge in
- Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
- Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.
- Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory
- Pembrolizumab.
Dr. Soonmo Peter Kang MD's Practice location
Soonmo Kang
5841 S Maryland Ave # Mc2115 Room Ab 107 -Chicago, IL 60637Get Direction
Dr. Soonmo Peter Kang MD's reviews
Write ReviewRecommended Articles
- Promising Results for Hodgkin Patients Using This Therapy
Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...
- Woman Who Battled Lymphoma Three Times Starts Support Group
Battling cancer is just that - a battle. To make it through once is an incredible feat, but one Virginia Beach woman survived the terrible condition three times. Now, she is starting a support group so other women can have the incredible outcome she had as well.Lynne's storyUnfortunately, most...
- The Link Between Melatonin and Lymphoma
There’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...
- Treatment Update for Hodgkin Lymphoma
Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...
- Treatments for Multiple Myeloma
The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...
- John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society
Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...
Nearby Providers
- Dr. Sowjanya Reganti M.D.,2160 S 1st Ave Maywood IL 60153
- Dr. Refat Baridi MD2320 High St Blue Island IL 60406
- Dr. Manjeet Chawla MD850 W Irving Park Rd Chicago IL 60613
- Dr. Nirmala Bhoopalam M.D.5TH AVENUE AND ROOSEVELT, HINES VA HOSPITAL HINES IL 60141
- Dr. Manuel Francisco Rosado M.D.5131 N Lincoln Ave Chicago IL 60625
- Dr. Alexander Starr MD71 W 156th St Harvey IL 60426
Nearest Hospitals
PROVIDENT HOSPITAL OF CHICAGOl
500 E 51ST ST CHICAGO IL 60615